Gaudium IVF and Women Health Limited (GAUDIUMIVF) — deviation variation | 13 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board approves Q1 FY2026 results, auditor reappointments, and IPO fund deviation
🔄 What Changed
Profit rose to ₹166.35 lakhs; IPO fund deviation reallocated unspent repayment to GCP
🔮 What's Next
AGM scheduled for September 28, 2026, to approve secretarial auditor appointment
💡 Investor Takeaway
Shareholders should note profit growth and IPO fund reallocation within regulatory limits

Gaudium IVF and Women Health Limited announced its Q1 FY2026 unaudited financial results on August 13, 2026, reporting revenue of ₹1,480.09 lakhs and profit of ₹166.35 lakhs, with EPS of ₹0.23. The Board approved re-appointing Ram Rattan & Associates as internal auditor and M/s. Suresh Nainwal & Company as secretarial auditor, subject to shareholder approval at the September 28 AGM. IPO proceeds of ₹9,000.08 lakhs saw ₹3,403.23 lakhs utilized by June 30, 2026, with remaining funds reallocated to General Corporate Purposes after deviation approval. Major expenditures exceeded 10% of total, including sales and marketing ([amount context mismatch] lakhs) and rent (₹63.12 lakhs).

📄 View Original Announcement (PDF)

About Gaudium IVF and Women Health Limited (GAUDIUMIVF)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹861.07 Cr P/E: 31.9 ROE: 50.0% ROCE: 52.1%

View full GAUDIUMIVF stock details →

📡 Get AI alerts when GAUDIUMIVF files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GAUDIUMIVF — Free

📊 More GAUDIUMIVF filings

See all GAUDIUMIVF filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GAUDIUMIVF files new disclosures

Track GAUDIUMIVF filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GAUDIUMIVF — Free

Free account · 2 AI queries/day